Its underlying mechanism involves inhibiting oxidative stress and inflammation through the AMPK/mTOR pathway and regulating the number of locally generated lymphatic vessels, thereby exerting a therapeutic effect on fatty liver. The gene discussed is MTOR; the disease is Hepatic steatosis.